Ryvu Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Read More
Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting
Read More
Ryvu Therapeutics appoints Hendrik Nogai, M.D. as Chief Medical Officer
Read More
Ryvu Therapeutics to participate in the LifeSci Partners 11th Annual Corporate Access Event and H.C. Wainwright Bioconnect Conference
Read More
